MED
Undervalued by 226.8% based on the discounted cash flow analysis.
Market cap | $140.14 Million |
---|---|
Enterprise Value | $57.20 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.19 |
Beta | 0.98 |
Outstanding Shares | 10,948,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -19.95 |
---|---|
PEG | 18.25 |
Price to Sales | 0.26 |
Price to Book Ratio | 0.67 |
Enterprise Value to Revenue | 0.11 |
Enterprise Value to EBIT | -9.17 |
Enterprise Value to Net Income | -9 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.04 |
No data
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...